An evidence-based approach to understanding the pharmacological class effect in the management of prostatic diseases.
about
Medical treatment of benign prostatic hyperplasia.Antitumor agents 290. Design, synthesis, and biological evaluation of new LNCaP and PC-3 cytotoxic curcumin analogs conjugated with anti-androgens.Advances in the development of hormonal modulators for the treatment of benign prostatic hyperplasia.Evidence-based medicine: comparative analysis of luteinizing hormone-releasing hormone analogues in combination with external beam radiation and surgery in the treatment of carcinoma of the prostate.
P2860
An evidence-based approach to understanding the pharmacological class effect in the management of prostatic diseases.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
An evidence-based approach to ...... agement of prostatic diseases.
@ast
An evidence-based approach to ...... agement of prostatic diseases.
@en
type
label
An evidence-based approach to ...... agement of prostatic diseases.
@ast
An evidence-based approach to ...... agement of prostatic diseases.
@en
prefLabel
An evidence-based approach to ...... agement of prostatic diseases.
@ast
An evidence-based approach to ...... agement of prostatic diseases.
@en
P2093
P2860
P1433
P1476
An evidence-based approach to ...... agement of prostatic diseases.
@en
P2093
Alexander R Zlotta
Christopher P Evans
John M Fitzpatrick
Neil Fleshner
P2860
P304
P356
10.1111/J.1464-410X.2005.05390.X
P577
2005-04-01T00:00:00Z